動物疫苗市場規模、佔有率和成長分析：按疫苗類型、動物類型、給藥途徑、最終用戶和地區分類－2026年至2033年產業預測

2024 年全球動物疫苗市場價值為 78 億美元，預計到 2033 年將從 2025 年的 83.2 億美元成長到 139.8 億美元，預測期（2026-2033 年）的複合年成長率為 6.7%。

由於動物疾病發病率上升和全球牲畜存欄量不斷成長，全球動物疫苗市場正經歷顯著成長。這一成長主要受肉類、牛奶和皮革等關鍵畜產品需求的驅動。狂犬病、馬流感和口蹄疫等疾病的主要疫苗透過增強免疫反應，在預防感染疾病傳播方面發揮著至關重要的作用。對糧食安全的擔憂以及畜牧環境的變化進一步推動了對高效畜禽疫苗的需求。此外，伴隨人口成長而來的生活方式和飲食習慣的改變也影響對畜產品的需求。先進疫苗的持續研發以及疾病的爆發正在重塑動物疫苗市場的格局。

全球動物疫苗市場成長要素

通用感染疾病率的不斷上升對人類健康和農業構成重大威脅，推動了對動物疫苗的需求。新興疾病和外來性疾病的出現，使得應對動物和人類的健康風險變得更加緊迫，同時也影響糧食安全。隨著人類和動物數量的持續成長，以及環境惡化和貿易旅行的全球化，物種間病原體傳播的可能性日益增加。這種情況為疾病管理和預防帶來了嚴峻挑戰，凸顯了在瞬息萬變的世界中，迫切需要有效的疫苗接種方案來保護動物和人類的健康。

全球動物疫苗市場限制因素

全球動物疫苗市場面臨許多限制因素，尤其是在非洲、亞洲和拉丁美洲等開發中地區。這些地區擁有約6億至9億小農戶，他們從事畜牧業。由於缺乏對疫苗益處的認知、疫苗價格高昂導致獲取途徑有限以及供應鏈不完善等問題，動物疫苗在這一領域的普及應用受到諸多挑戰的阻礙。因此，許多農民的牲畜死於可預防的疾病，進一步加劇了他們的經濟困境。為了解決這些問題，目前正在進行多項旨在提高小規模農戶取得、使用和負擔得起疫苗的措施。

全球動物疫苗市場趨勢

全球動物疫苗市場正呈現顯著上升趨勢，這主要得益於公共和私人部門對特定研究舉措的投入增加以及動物疫病爆發的激增。此外，技術進步推動的創新產品研發也促進了這一趨勢。策略合作的加強、網路普及率的提高以及大眾對通用感染疾病認知的提高等因素，都使市場前景日益光明。此外，診斷和治療方法的進步，尤其是在發展中地區，以及人均醫療保健支出的成長，都為這個充滿活力的市場中的相關人員創造了廣闊的發展機會。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球動物疫苗市場規模：依疫苗類型分類

• 減毒活病毒疫苗
• 去活化疫苗
• 重組疫苗

全球動物疫苗市場規模：以動物類型分類

• 寵物
  • 狗
  • 貓
• 家畜
  • 牛
  • 豬

全球動物疫苗市場規模：依給藥途徑分類

• 注射藥物
• 鼻內
• 口服

全球動物疫苗市場規模：依最終用戶分類

• 動物診所
• 農民
• 研究機構

全球動物疫苗市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis
• Merck Animal Health
• Elanco
• Boehringer Ingelheim Animal Health
• Bayer Animal Health
• Ceva Sante Animale
• Virbac
• HIPRA
• Vetoquinol
• Neogen Corporation
• IDEXX Laboratories
• TheraCell
• Provimi
• Agrivet
• Avanti International
• Parnell Pharmaceuticals
• Kemin Industries
• Animal Health International
• QIAGEN
• DVM Pharmaceuticals

結論與建議

Global Animal Vaccines Market size was valued at USD 7.8 Billion in 2024 and is poised to grow from USD 8.32 Billion in 2025 to USD 13.98 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The market for global animal vaccines is experiencing significant growth due to heightened outbreaks of animal diseases and a rising livestock population worldwide. This growth is fueled by a demand for essential animal products, including meat, milk, and leather. Key vaccines, such as those for rabies, equine influenza, and foot-and-mouth disease, play a vital role in preventing the spread of infectious diseases by enhancing immune response. Concerns about food security and the evolving landscape of animal husbandry are driving further demand for effective livestock vaccines. Additionally, changing lifestyles and dietary preferences linked to population growth are influencing the need for livestock products. The ongoing development of advanced vaccines, alongside disease outbreaks, is reshaping the dynamics within the animal vaccines market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Vaccines Market Segments Analysis

Global Animal Vaccines Market is segmented by Vaccine Type, Animal Type, Administration Route, End User and region. Based on Vaccine Type, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines and Recombinant Vaccines. Based on Animal Type, the market is segmented into Pets and Livestock. Based on Administration Route, the market is segmented into Injectable, Intranasal and Oral. Based on End User, the market is segmented into Veterinary Clinics, Farmers and Research Institutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Vaccines Market

The rising occurrence of zoonotic diseases poses significant threats to both human health and agriculture, driving the demand for animal vaccines. The emergence of new and exotic diseases adds urgency to addressing health risks for both animals and humans, while also impacting food security. As human and animal populations continue to grow, alongside environmental degradation and the globalization of trade and travel, the likelihood of pathogen transmission between species escalates. This situation creates substantial challenges related to disease management and prevention, highlighting the crucial need for effective vaccination solutions to safeguard both animal and human health in a rapidly changing world.

Restraints in the Global Animal Vaccines Market

The Global Animal Vaccines market faces significant constraints, particularly in developing regions such as Africa, Asia, and Latin America, where an estimated 600-900 million smallholder farmers raise livestock. Adoption of animal vaccinations within this demographic is hindered by several challenges, including a lack of awareness regarding the advantages of immunization, limited access due to high costs of vaccines, and an inadequate supply chain that restricts availability. Consequently, many livestock owned by these farmers succumb to preventable diseases, exacerbating their economic hardships. To address these issues, various initiatives are underway aimed at enhancing vaccine accessibility, availability, and affordability for smallholder farmers.

Market Trends of the Global Animal Vaccines Market

The Global Animal Vaccines market is witnessing a significant upward trend driven by an increase in public-private funding aimed at targeted research initiatives and a surge in the prevalence of animal diseases. This is further propelled by innovative product developments spurred by technological advancements. The market landscape is becoming increasingly favorable, with strategic alliances on the rise, enhanced internet penetration fueling information dissemination, and growing public concern over zoonotic diseases. Additionally, advances in diagnostics and therapeutics, particularly in developing regions, combined with a rise in per capita healthcare expenditure, are creating promising opportunities for stakeholders in this dynamic market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Animal Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Live Attenuated Vaccines
• Inactivated Vaccines
• Recombinant Vaccines

Global Animal Vaccines Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Pets
  • Dogs
  • Cats
• Livestock
  • Cattle
  • Pigs

Global Animal Vaccines Market Size by Administration Route & CAGR (2026-2033)

• Market Overview
• Injectable
• Intranasal
• Oral

Global Animal Vaccines Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Farmers
• Research Institutions

Global Animal Vaccines Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Animal Type, Administration Route, End User)
  • US
  • Canada
• Europe (Vaccine Type, Animal Type, Administration Route, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Animal Type, Administration Route, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Animal Type, Administration Route, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Animal Type, Administration Route, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TheraCell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Provimi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrivet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanti International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parnell Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animal Health International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DVM Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations